Vibegron

N/A

Report date: 2025/01/12 20:00:04
NME

Base Information

Drug NameVibegron
Drug Alias Name维勃隆vibegronumBivegron维贝隆维贝格龙 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-3 adrenergic receptor agonists
TargetsBeta-3 adrenergic receptor
Therapy Area/IndicationsObesityUrinary IncontinenceUrinary Bladder, Overactive +[5] 
Global Approved IndicationsUrinary IncontinenceUrinary Bladder, Overactive
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2018/09/21
Country/TerritoryBelgiumCanadaUnited States +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesMerck & Co IncRoivant Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesSumitomo Pharma America IncUrovant SciencesPierre Fabre Medicament SAS +[7] 
Inactive CompaniesMerck Sharp & Dohme CorpSinovant Sciences Hk LtdMerck Sharp & Dohme LLC +[4] 
Active IndicationsObesityUrinary IncontinenceUrinary Bladder, Overactive +[4] 
Inactive IndicationsIrritable Bowel Syndrome

Other Information

ATC CodeG04BD
Related LinksDrugBankKEGG